Market revenue in 2024 | USD 6,617.0 million |
Market revenue in 2030 | USD 10,408.9 million |
Growth rate | 7.9% (CAGR from 2025 to 2030) |
Largest segment | Non-cold chain logistics |
Fastest growing segment | Cold Chain Logistics |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cold Chain Logistics, Non-cold Chain Logistics |
Key market players worldwide | DHL Group, SF Express, United Parcel Service Inc Class B, AmerisourceBergen Drug Corporation, DB Schenker, Kuehne + Nagel International AG, Kerry Logistics Network Ltd, Agility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical third-party logistics market will help companies and investors design strategic landscapes.
Non-cold chain logistics was the largest segment with a revenue share of 83.19% in 2024. Horizon Databook has segmented the Japan biopharmaceutical third-party logistics market based on cold chain logistics, non-cold chain logistics covering the revenue growth of each sub-segment from 2018 to 2030.
Japan biopharmaceutical third party logistics market accounted for 28.8% market share in 2020 in the Asia Pacific market. According to the World Bank, the Logistics Performance Index (LPI) score of Japan was 4.03 in 2018.
An impressive LPI score coupled with well-established freight transportation sector creates suitable environment for the growth of Japan biopharmaceutical third party logistics market.
For instance, according to OECD, 210,467 million tonne-km of freight transport was completed in the country in 2018. Huge biopharmaceutical R&D investment will also propel the Japan biopharmaceutical third party logistics market.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan biopharmaceutical third-party logistics market , including forecasts for subscribers. This country databook contains high-level insights into Japan biopharmaceutical third-party logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account